These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20882255)

  • 41. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
    Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
    Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.
    Cardoso CR; de Aguiar I; Camilo MR; Lima MV; Ito AS; Baptista MS; Pavani C; Venâncio T; Carlos RM
    Dalton Trans; 2012 Jun; 41(22):6726-34. PubMed ID: 22539182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.
    Tan C; Hu S; Liu J; Ji L
    Eur J Med Chem; 2011 May; 46(5):1555-63. PubMed ID: 21354673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New ruthenium(II) complexes with N-alkylphenothiazines: synthesis, structure, in vivo activity as free radical scavengers and in vitro cytotoxicity.
    Krstić M; Sovilj SP; Grgurić-Sipka S; Radosavljević Evans I; Borozan S; Santibanez JF; Kocić J
    Eur J Med Chem; 2010 Sep; 45(9):3669-76. PubMed ID: 20684856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.
    Kljun J; Rebernik M; Balsa LM; Kladnik J; Rapuš U; Trobec T; Sepčić K; Frangež R; León IE; Turel I
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes.
    Adams M; de Kock C; Smith PJ; Land KM; Liu N; Hopper M; Hsiao A; Burgoyne AR; Stringer T; Meyer M; Wiesner L; Chibale K; Smith GS
    Dalton Trans; 2015 Feb; 44(5):2456-68. PubMed ID: 25559246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2].
    Miranda S; Vergara E; Mohr F; de Vos D; Cerrada E; Mendía A; Laguna M
    Inorg Chem; 2008 Jul; 47(13):5641-8. PubMed ID: 18447334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolization of [Ru(eta(6)-C (6)H (5)CF (3))(pta)Cl (2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand.
    Egger AE; Hartinger CG; Renfrew AK; Dyson PJ
    J Biol Inorg Chem; 2010 Aug; 15(6):919-27. PubMed ID: 20364440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
    Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
    J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, X-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole)Ru(III) complexes.
    Arion VB; Reisner E; Fremuth M; Jakupec MA; Keppler BK; Kukushkin VY; Pombeiro AJ
    Inorg Chem; 2003 Sep; 42(19):6024-31. PubMed ID: 12971773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)](+/2+) (X = Cl, H2O; L = bpmo, bpms) complexes.
    Tripathy SK; Taviti AC; Dehury N; Sahoo A; Pal S; Beuria TK; Patra S
    Dalton Trans; 2015 Mar; 44(11):5114-24. PubMed ID: 25675378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
    Tan C; Liu J; Chen L; Shi S; Ji L
    J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, characterization, antiproliferative and molecular docking study of new half sandwich Ir(III), Rh(III) and Ru(II) complexes.
    Thangavel S; Paulpandi M; Friedrich HB; Murugan K; Kalva S; Skelton AA
    J Inorg Biochem; 2016 Jun; 159():50-61. PubMed ID: 26918899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
    Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Water-soluble Cp ruthenium complex containing 1,3,5-triaza-7-phosphaadamantane and 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity.
    Hajji L; Saraiba-Bello C; Romerosa A; Segovia-Torrente G; Serrano-Ruiz M; Bergamini P; Canella A
    Inorg Chem; 2011 Feb; 50(3):873-82. PubMed ID: 21226474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
    Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
    J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.
    Nhukeaw T; Hongthong K; Dyson PJ; Ratanaphan A
    Apoptosis; 2019 Aug; 24(7-8):612-622. PubMed ID: 31016421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
    do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
    J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.